<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8 - K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) FEBRUARY 3, 1998
GALILEO CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 04-2526583
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
0-11309
(Commission File Number)
GALILEO PARK, P.O. BOX 550, STURBRIDGE, MASSACHUSETTS 01566
(Address of principal executive offices) (Zip Code)
Registrant's telephone number including area code (508) 347-9191
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
1
<PAGE> 2
Item 5. OTHER INFORMATION
On February 4, 1998, the Registrant acquired all of the outstanding
shares of Les Entreprises Galenica, Inc. ("Galenica") for
approximately US$3.2 million in cash. Galenica, a privately held
company based near Montreal, Canada, manufactures and markets a
broad line of disposable, single-use vaginal specula. Galenica's
revenues for 1997 were in excess of US$3.0 million.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
a) Financial Statements of Business Acquired
Not applicable.
b) Pro Forma Financial Information
Not applicable.
c) Exhibits
99.1 Press Release dated February 4, 1998.
2
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GALILEO CORPORATION
Date: February 6, 1998 By: /S/ JOSEF W. ROKUS
-------------------------------------
Josef W. Rokus
Vice President, Corporate Development
and Secretary
3
<PAGE> 4
EXHIBIT INDEX
EXHIBIT NO.
-----------
99.1 Press Release dated February 4, 1998.
4
<PAGE> 1
- --------------------------------------------------------------------------------
GALILEO NEWS
- --------------------------------------------------------------------------------
EXHIBIT 99.1
Investor Relations - Gregory Riedel (508) 347-4222
GALILEO ACQUIRES LES ENTREPRISES GALENICA, INC.
- --------------------------------------------------------------------------------
STURBRIDGE, MA, FEBRUARY 4, 1998 - Galileo Corporation (NASDAQ National Market:
GAEO) announced today that it has acquired Les Entreprises Galenica, Inc.
("Galenica"), a privately held company, based in near Montreal, Canada. Galileo
will acquire all of the outstanding shares of Galenica for approximately US$3.2
million in cash. Galenica manufactures and markets a broad line of disposable,
single-use vaginal specula, the most frequently used diagnostic instrument used
by OB/GYN physicians, clinics and hospitals. These products are marketed
primarily in the United States, Canada, Latin America and Europe through an
extensive international distributor network. Last year's revenues were in excess
of US$3.0 million.
William T. Hanley, President and Chief Executive Officer, commented, "We are
very pleased to add Galenica's devices to Leisegang Medical's growing product
portfolio. This acquisition represents a continuation of our strategy to
position Galileo as a provider of high-quality women's health diagnostic
products and strengthens our presence in this growing worldwide market."
Dr. Jacques R. Marcotte, President, Galenica, stated, "Our customers will
significantly benefit from Galenica's strengths in international distribution
which will expand the global presence for all of Galileo's products and our
fully-integrated manufacturing facility which will ensure the highest product
quality."
Galileo Corporation Galileo Park P.O. Box 550 Sturbridge, MA 01566 USA
TEL. (508) 347-9191 FAX (508) 347-3849
World Wide Web Site: http://www.galileocorp.com
<PAGE> 2
Galileo, along with its recently acquired wholly-owned subsidiary, OFC
Corporation, develops, manufactures and markets products based on its core
optical and photonic technologies for applications in medical products and
instruments, telecommunication products, analytical instruments and office
equipment. The Company markets its products to OEMs, through marketing partners
and direct to end-users. Leisegang Medical, a wholly-owned subsidiary, develops,
manufactures, and markets women's health-related medical products. Please visit
our web sites at www.galileocorp.com and www.ofccorp.com for additional
information.
